A new analysis by the Dartmouth Medical School questions the benefits of a widely accepted sepsis treatment called tight glucose control. This treatment is used for patients not only with sepsis, but also with other critical illnesses. The Dartmouth researchers are concerned the treatment not only might not help such patients, it could cause harm.
Tight glucose control involves nurses testing patients’ blood-sugar levels hourly, and, if required, adjusting intravenous insulin drips. The treatment began being heavily promoted by medical groups such as the Surviving Sepsis Campaign back in 2004. That promotion was prompted on one study, which took place in Belgium that indicated that critical-care patients often had high blood sugar that could lead to fatal complications. (more…)

